Newsletter
Cannabis biz PAC donations are boosting anti-legalization lawmakers (Newsletter: September 15, 2026)
Congress to vote on marijuana & drug testing bill; FDA psychedelics plan; San Francisco cannabis cafe regs; Study: Medical marijuana & cancer symptoms
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today.
https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
A Trump-linked PAC is using money raised from marijuana industry contributions to support 11 vulnerable Republican members of Congress—including several who have voted against legalizing cannabis or advocated against federal rescheduling.
The House of Representatives is set to vote this week on a bill to require the Department of Health and Human Services to study how prevalent drug testing for marijuana, fentanyl and other drugs is in hospital emergency departments.
Food and Drug Administration officials are laying out the agency’s plan to “make psychedelic therapies available to patients more quickly, as warranted by the nation’s mental health crisis.”
The San Francisco, California Office of Cannabis filed proposed rules for cannabis cafes where people could consume marijuana while listening to live music and ordering food and beverages.
The Minnesota Office of Cannabis Management published a study finding that people with cancer “reported decreased nausea, vomiting, anxiety, and depression scores within four months” of starting medical marijuana.
- Involving more than 6,500 patients, it is “one of the largest studies ever involving medical cannabis treatment,” officials said.
/ FEDERAL
Customs and Border Protection published a notice of intent to sole source cannabis analyzation devices.
Sen. Catherine Cortez Masto (D-NV) sent a press release about her cosponsorship of a marijuana banking bill.
Texas Democratic U.S. Senate candidate James Talarico criticized his Republican opponent Ken Paxton for dodging questions about the state’s cannabis restrictions and other issues, though he himself said he is “declining to answer” whether he partook in marijuana use with Willie Nelson at a recent event.
/ STATES
Maryland Gov. Wes Moore (D) touted his mass cannabis pardons.
Kansas Democratic gubernatorial candidate Cindy Holscher said the state should legalize marijuana to generate revenue during a debate.
Pennsylvania’s attorney general touted enforcement actions against a network reportedly behind the sales of THC products in stores across the state.
The West Virginia legislature’s Joint Committee on Health heard testimony about the therapeutic benefits of psilocybin.
Colorado regulators are being sued over their efforts to shutter an unlicensed psilocybin provider.
Alaska regulators filed proposed changes to medical cannabis rules.
California regulators reportedly shuttered a marijuana cultivation operation connected to the death of a worker after allegedly discovering “adulterated” product and pesticide rules violations.
The Rhode Island Cannabis Control Commission will meet on Friday.
The Virginia Cannabis Control Authority Board of Directors will meet on October 21.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
The Baltimore, Maryland City Council’s Legislative Investigations Committee held a hearing on a bill to crack down on stores that illegally sell cannabis products.
/ INTERNATIONAL
French officials are not responding to questions about apparent delays in issuing medical cannabis regulations.
/ SCIENCE & HEALTH
A case study “highlights the potential role of medical cannabis as an adjunctive therapy in the rehabilitation of severe [traumatic brain injury], particularly in addressing complex neurological and functional impairments.”
/ BUSINESS
High Tide Inc. reported quarterly revenue of C$198.8 million.
Curaleaf Holdings, Inc. and Aurora Cannabis Inc. continued to trade attacks over the former company’s unsolicited bid to acquire the latter.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
